Introduction {#s1}
============

Diabetes is often accompanied by gastrointestinal (GI) motility dysfunction ([@B1]). The gastric complications of diabetes are frequently attributed to an enteric neuropathy, primarily due to loss or reduced expression of neuronal nitric oxide synthase (NOS1) inhibitory neurons ([@B2],[@B3]). Conversely, reduced populations of excitatory enteric neurons have also been reported ([@B4]). Disruption of gastric interstitial cells of Cajal (ICC) has also been reported in animal models of diabetes ([@B5],[@B6]) and in human patients ([@B7],[@B8]). Studies have shown that ICC are the GI pacemaker cells that generate electrical slow waves that underlie phasic contractions throughout the GI tract ([@B9]--[@B11]). These cells also act as intermediaries in enteric neuroeffector transmission ([@B12],[@B13]). Thus, defects or loss of ICC may be involved in the pathological motor activities in gastroparesis. Aberrant electrical activity ([@B5]), development of delayed gastric emptying, and loss of ICC have been observed concomitantly in animal models of diabetes ([@B14],[@B15]). In contrast, an increase, rather than a decrease, in gastric emptying has been observed in ∼20% of patients with diabetes ([@B16]). Recently, an increase in gastric ICC numbers and increased cholinergic motor responses have been detected in female *Lepr^db^* mice, and these changes were associated with accelerated gastric emptying ([@B17]). Overall, the pathogenesis of the GI motor complications of diabetes remains poorly understood, and there is a paucity of studies examining changes in ICC, enteric neurons, and the functional deficits associated with type 2 diabetes.

Prostaglandins are biologically active lipid derivatives of arachidonic acid that are synthesized in GI muscles ([@B18]). Arachidonic acid is liberated from membrane phospholipids by phospholipase A~2~ and subsequently converted to prostaglandin H~2~ (PGH~2~) by the prostaglandin-endoperoxide synthase (PTGS) enzymes (also known as cyclooxygenases). Two isoforms of PTGS exist: PTGS1 and PTGS2. PTGS1 is constitutively expressed, whereas PTGS2 expression is generally low under normal conditions but can be induced by inflammation ([@B19]). However, constitutive expression of PTGS2 has been observed in intramuscular ICC (ICC-IM) and enteric neurons of the GI tract ([@B20],[@B21]). PGH~2~ is then converted to various prostaglandins and thromboxane (i.e., PGE~2~, PGD~2~, PGF~2α~, PGI~2~, and thromboxane A2; see [Fig. 7](#F7){ref-type="fig"}) by several specific prostaglandin synthase enzymes ([@B22]). For example, PGE~2~ is produced by microsomal PGE~2~ synthase (PTGES or mPGES). Like PTGS, there are multiple isoforms of this enzyme (PTGES, PTGES2, and PTGES3), of which PTGES2 and PTGES3 are constitutively expressed and PTGES is induced by inflammatory mediators ([@B19]).

Endogenous prostaglandins (particularly PGE~2~) affect gastric motility. PGE~2~ affects pacemaker activity in the antrum by increasing the frequency and decreasing the amplitude of slow waves ([@B23],[@B24]). PGE~2~ also inhibits phasic contractions in the antrum but enhances contractile tone in the proximal stomach ([@B20],[@B23]). Consequently, this disrupts the coordination of gastric peristalsis in intact muscles ([@B24]). The effects of PGE~2~ on antral activity are absent in *W/W^v^* mice, which lack gastric ICC-IM, suggesting that these effects are mediated by receptors on ICC-IM ([@B24]). The chronotropic receptor expressed by ICC is the EP3 subtype (PTGER3) ([@B24],[@B25]).

We investigated gastric electrical and mechanical activities of *Lep^ob^* mice and observed that the abnormal patterns of activity were similar to behaviors caused by PGE~2~ administration. Therefore, we investigated the hypothesis that the gastric motor abnormalities seen in this diabetic animal model might be related to overproduction of PGE~2~, working through receptors in ICC that affect pacemaker activity. We used immunohistochemical, molecular, and functional approaches to characterize enteric nerves, interstitial cell populations, and changes in the molecules that enhance PGE~2~ signaling and characterize electromechanical patterning of gastric muscles of *Lep^ob^* mice. Our results show that *Lep^ob^* mice have slow waves of increased frequency and decreased amplitude. Areas of antrum were found with no resolvable pacemaker activity, and these electrical anomalies were associated with abnormal contractile patterns. We also found increased expression of specific components of the prostaglandin pathway, including PTGES1 and PGE~2~ receptors, which may underlie the observed changes in gastric motility patterns.

Research Design and Methods {#s2}
===========================

Animals {#s3}
-------

*Lep^ob^* diabetic mice and wild-type littermates (C57BL/6) were obtained from The Jackson Laboratory (Bar Harbor, ME). *Lep^ob^* mice (8--10 weeks old) had greater weights: 48 ± 3 g (*n* = 6) vs. 23 ± 1 g for wild-types (*n* = 5; *P* ≤ 0.0001). Animals were anesthetized by isoflurane (Baxter, Deerfield, IL) and exsanguinated after cervical dislocation. Blood glucose was measured from tail tips using an Ascensia-Contour Blood Glucose Monitoring System (Bayer HealthCare LLC, Mishawaka, IN). *Lep^ob^* mice were hyperglycemic, 256 ± 30 mg/dL (*n* = 15) vs. 154 ± 7 mg/dL for wild-type mice (*n* = 10; *P* = 0.014). Stomachs from age-matched *Lep^ob^* mice and wild-type controls were removed and opened along the lesser curvature, and the antral mucosa removed by sharp dissection. All experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The Institutional Animal Use and Care Committee at the University of Nevada, Reno approved procedures.

Electrophysiological Measurements {#s4}
---------------------------------

Antral muscles were pinned to the Sylgard elastomer floor of a recording chamber and perfused with 37°C Krebs-Ringer buffer. Circular muscle cells were impaled with KCl-filled glass microelectrodes (50--100 MΩ). Transmembrane potentials were measured using an amplifier (Axon Instruments, Sunnyvale, CA) and digitized (Digidata 1300 series; Axon Instruments). Slow waves were recorded from nine mapped regions of each antrum. Measurements of resting membrane potential (RMP), amplitude, frequency, half-maximal duration, and interslow wave period (ISWP) were made using Clampfit 10.0 (Axon Instruments).

Postjunctional neural responses were recorded in response to electrical field stimulation (0.3-ms pulse duration, 1--20 Hz, train durations of 1 s, 10--15 V) delivered by a Grass S48 stimulator (Grass Instruments, Quincy, MA).

Isometric Force Measurements {#s5}
----------------------------

Standard isometric force measurements were performed as previously described ([@B20]). Details are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

Video Imaging of Gastric Peristalsis {#s6}
------------------------------------

Motility patterns of antrums were recorded as previously described ([@B24]). Specific details are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

Immunohistochemistry {#s7}
--------------------

Immunohistochemistry of whole-mount gastric preparations was performed as previously described ([@B26]). Specific details are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1) and [Supplementary Table 1](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1) for antibodies used.

Western Blot Analysis {#s8}
---------------------

Western blot analysis was performed using standard techniques and as previously described ([@B27]). Details are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

RNA Isolation and Real-Time Quantitative PCR {#s9}
--------------------------------------------

RNA isolation and quantitative PCR (qPCR) performed using standard techniques ([@B28]). Details are provided in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

Solutions and Drugs {#s10}
-------------------

Details of solutions and drugs used are described in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

Statistical Analysis {#s11}
--------------------

Standard statistical analysis was performed using appropriate statistical tests. Details are described in the [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

Results {#s12}
=======

Disruption of Pacemaker Activity in Gastric Antrums of *Lep^ob^* Diabetic Animals {#s13}
---------------------------------------------------------------------------------

The RMP for gastric antrums of wild-type mice averaged −66 ± 4.0 mV (*n* = 14), whereas the antrums of *Lep^ob^* mice were significantly depolarized at −60 ± 5.0 mV (*n* = 16; *P* = 0.001). Slow waves occurred in wild-type antrums with a frequency of 3.6 ± 0.7 min^−1^ ([Fig. 1*A* and *C*](#F1){ref-type="fig"}) (*n* = 14), but the frequency of slow waves was increased in *Lep^ob^* antral muscles to 5.2 ± 1.9 min^−1^ ([Fig. 1*B* and *C*](#F1){ref-type="fig"}) (*n* = 16; *P* = 0.0049). Slow waves from wild-type mice had an average amplitude of 29 ± 6.0 mV ([Fig. 1*A* and *D*](#F1){ref-type="fig"}) (*n* = 14) but were only 19 ± 8 mV in *Lep^ob^* antral muscles ([Fig. 1*B* and *D*](#F1){ref-type="fig"}) (*n* = 16; *P* = 0.0002). The ISWP was 9.8 ± 3.7 s in wild-type mice ([Fig. 1*A* and *E*](#F1){ref-type="fig"}) (*n* = 14) and significantly reduced to 4 ± 1.9 s in *Lep^ob^* mice ([Fig. 1*B* and *E*](#F1){ref-type="fig"}) (*n* = 14; *P* \< 0.0001). The half-duration of slow waves in wild-type (4.4 ± 1.5 s) ([Fig. 1*A* and *F*](#F1){ref-type="fig"}) (*n* = 14) and *Lep^ob^* antral muscles (3.2 ± 2.3 s) ([Fig. 1*B* and *F*](#F1){ref-type="fig"}) was not significantly different (*n* = 16; *P* = 0.1085). Of the 16 *Lep^ob^* antrums studied, 2 had slow wave frequencies, and 4 had amplitudes that were not different from the average values of slow waves in wild-type mice. All animals were included in the analysis of electrical parameters.

![Frequency of pacemaker activity was greater, and amplitude reduced, in *Lep^ob^* antrums. Representative intracellular microelectrode recordings from the antrums of wild-type (*A*) and *Lep^ob^* (*B*) mice. Note the depolarized membrane potential, increased frequency, and decreased amplitude of slow waves in *Lep^ob^* antrums. Time scale in *B* applies to both *A* and *B*. *C--F*: Summarized data demonstrating differences in slow wave parameters between wild-type (white bars) and *Lep^ob^* antrums (black bars). Increase in slow wave frequency (*C*), reduction in slow wave amplitude (*D*), reduction in ISWP (*E*), and reduction in half-maximal duration of slow waves (*F*) (unpaired Student *t* test). Representative isometric force recordings from the antrums of wild-type (*G*) and *Lep^ob^* (*H*) mice. Summarized data showing increased frequency (*I*) and reduced amplitude (*J*) of contractions in *Lep^ob^*, as compared with wild-type (unpaired Student *t* test). \**P* ≤ 0.05; \*\**P* ≤ 0.01; \*\*\**P* ≤ 0.001; \*\*\*\**P* ≤ 0.0001.](db181064f1){#F1}

Intracellular recordings were made at nine specific regions along the antral wall from greater to lesser curvature to determine if the disruption in slow wave activity was widely distributed or a localized occurrence. [Figure 2*A* and *B*](#F2){ref-type="fig"} shows a diagrammatic representation of the preparation and the location of each recording site. Typical slow waves from each region are shown in [Fig. 2*C* and *D*](#F2){ref-type="fig"}. In the gastric antrums of wild-type animals, slow waves tended to have reduced amplitudes in the distal antrum compared with proximal regions (compare regions 7--9 with regions 1--3 in [Fig. 2*C*](#F2){ref-type="fig"}). The slow wave pattern was more heterogeneous in *Lep^ob^* antrums, with some regions (e.g., regions [@B7] and [@B8]) displaying an absence of slow waves ([Fig. 2*D*](#F2){ref-type="fig"}). Summary data reveal significantly increased slow wave frequencies and reduced amplitudes in numerous antral regions ([Supplementary Fig. 3](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)). Means ± SD from the nine recorded regions are shown in [Supplementary Table 4](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1).

![Mapping of pacemaker activity throughout the antrums of wild-type and *Lep^ob^* animals. *A* and *B*: Diagrammatic illustrations showing the gastric antrum muscle preparation and the regions from which electrical recordings were obtained. *A*: Antrums were separated from intact stomachs and opened along the lesser curvature (LC). *B*: Isolated antrums were pinned flat, the mucosa removed, and intracellular microelectrode recordings made from proximal antrum (regions 1--3), mid antrum (regions 4--6), and the terminal antrum (regions 7--9). Typical electrical activity recorded from the circular muscle layers of each of the nine regions of wild-type (*C*) and *Lep^ob^* antrums (*D*). Note that membrane potentials were more depolarized and pacemaker activity was higher in frequency and decreased in amplitude in *Lep^ob^* antrums compared with wild-type controls. In two regions of the *Lep^ob^* antrum, no slow wave activity was recorded. GC, greater curvature.](db181064f2){#F2}

Postjunctional Neural Responses in Gastric Antrums of *Lep^ob^* Animals {#s14}
-----------------------------------------------------------------------

We recorded postjunctional neural responses to electrical field stimulation of intrinsic neurons in wild-type and *Lep^ob^* antrums. No significant differences were observed in responses at 1 and 10 Hz (see [Supplementary Data](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1) and [Supplementary Fig. 2](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)).

Antral Mechanical Activity Is Decreased and Motility Is Disordered in *Lep^ob^* Diabetic Mice {#s15}
---------------------------------------------------------------------------------------------

Isometric force measurements revealed that phasic contractions of *Lep^ob^* antrums were reduced in amplitude and increased in frequency in comparison with antral muscles of wild-type mice. Circular muscle contractions occurred at 3.0 ± 1.1 min^−1^ ([Fig. 1*G* and *I*](#F1){ref-type="fig"}) (*n* = 15) and generated 1.9 ± 0.51 mN of force in wild-type muscles ([Fig. 1*G* and *J*](#F1){ref-type="fig"}) (*n* = 8). Contractions of *Lep^ob^* antrums occurred at 4.1 ± 1.4 min^−1^ ([Fig. 1*H* and *I*](#F1){ref-type="fig"}) (*n* = 14; *P* = 0.033) and generated significantly less force (0.85 ± 0.37 mN) ([Fig. 1*H* and *J*](#F1){ref-type="fig"}) (*n* = 9; *P* ≤ 0.001).

Video imaging of antral muscles from wild-type or *Lep^ob^* mice was also performed to determine changes in motility patterns ([Supplementary Fig. 1*A--C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)). Spatiotemporal maps were produced from video recordings ([Supplementary Fig. 1*D* and *E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)). Wild-type antral muscles demonstrated robust regular contractions at a frequency of 4 min^−1^ ([Supplementary Fig. 1*D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)). This activity was weakened, irregular, and occurred at a higher frequency of 5.5 min^−1^ in *Lep^ob^* antrums ([Supplementary Fig. 1*E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)).

ICC Networks, NOS1^+^ Nerves, and PDGFRα^+^ Cells in Wild-Type and *Lep^ob^* Mice {#s16}
---------------------------------------------------------------------------------

Images from the greater curvature are presented in [Fig. 3](#F3){ref-type="fig"}. [Supplementary Fig. 4](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1) shows images from the lesser curvature. No differences were observed in ICC at the level of the myenteric plexus (ICC-MY) between wild-type ([Fig. 3*B*](#F3){ref-type="fig"} and [Supplementary Fig. 4*B*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 7) and *Lep^ob^* mice ([Fig. 3*D*](#F3){ref-type="fig"} and [Supplementary Fig. 4*D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 10) and ICC-IM in wild-type ([Fig. 3*A*](#F3){ref-type="fig"} and [Supplementary Fig. 4*A*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 7) and *Lep^ob^* antrums ([Fig. 3*C*](#F3){ref-type="fig"} and [Supplementary Fig. 4*C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 10). Likewise, no differences were detected in the densities of NOS1^+^ nerve fibers in the circular muscle layer of wild-type ([Fig. 3*E*](#F3){ref-type="fig"} and [Supplementary Fig. 4*E*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 3) and *Lep^ob^* mice ([Fig. 3*G*](#F3){ref-type="fig"} and [Supplementary Fig. 4*G*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 6). NOS1^+^ neurons were also unchanged in the myenteric plexus of antrums of wild-type ([Fig. 3*F*](#F3){ref-type="fig"} and [Supplementary Fig. 4*F*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 3) and *Lep^ob^* mice ([Fig. 3*H*](#F3){ref-type="fig"} and [Supplementary Fig. 4*H*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 6).

![Networks of ICC, NOS1^+^ nerves, and PDGFRα^+^ cells along the greater curvature of antrums from wild-type and *Lep^ob^* animals. Representative images of ICC (*A--D*), NOS1^+^ neurons (*E--H*), and PDGFRα^+^ cells (*I--L*). *A*, *E*, and *I* show ICC, NOS1^+^ nerve fibers, and PDGFRα^+^ cells, respectively, within the circular muscle layer of a wild-type antrum. *B*, *F*, and *J* show ICC, NOS1^+^ neurons, and PDGFRα^+^ cells, respectively, in the myenteric plexus region of a wild-type antrum. *C*, *G*, and *K* show ICC, NOS1^+^ nerve fibers, and PDGFRα^+^ cells, respectively, within the circular muscle layer of a *Lep^ob^* antrum. *D*, *H*, and *L* show ICC, NOS1^+^ neurons, and PDGFRα^+^ cells, respectively, in the myenteric plexus region of a *Lep^ob^* antrum. Scale bar in *L* applies to all panels.](db181064f3){#F3}

Platelet-derived growth factor receptor α^+^ (PDGFRα^+^) cells had similar densities in antral circular muscles of wild-type ([Fig. 3*I*](#F3){ref-type="fig"} and [Supplementary Fig. 4*I*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 5) and *Lep^ob^* mice ([Fig. 3*K*](#F3){ref-type="fig"} and [Supplementary Fig. 4*K*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 4). No differences in PDGFRα ^+^ cells were detected in the myenteric region either ([Fig. 3*J*](#F3){ref-type="fig"} and [Supplementary Fig. 4*J*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1), *n* = 5; [Fig. 3*L*](#F3){ref-type="fig"} and [Supplementary Fig. 4*L*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1), *n* = 4).

Protein Expression in ICC, Enteric Neurons, and Smooth Muscle in Wild-Type and *Lep^ob^* Mice {#s17}
---------------------------------------------------------------------------------------------

Western blot analysis was performed to quantify possible changes in cell-specific proteins expressed in ICC (KIT), enteric neurons (NOS1 and UCHL1), smooth muscle (MYH11), and in pre- and postsynaptic proteins (SNAP25, syntaxin, and DLG4). No significant differences were observed in any of these proteins between wild-type (*n* = 4) and *Lep^ob^* antrums (*n* = 3) ([Fig. 4](#F4){ref-type="fig"}).

![Western blot analysis for proteins relating to ICC, enteric nerves, and MYH11 cells in antrums from *Lep^ob^* and wild-type animals. *A*: Representative Western blots comparing the expression of various proteins associated with ICC (KIT; DLG4), enteric nerves (NOS1; UCHL1, SNAP25, and syntaxin), and MYH11 in wild-type and *Lep^ob^* mice, respectively. Each band is demarcated by a boundary box to illustrate that they were from different gels or different parts of the same gel. Bands are the most representative from the gastric antrums of three different animals. GAPDH was used as a control housekeeping protein to which the other proteins were compared. Three separate GAPDH blots, one from each animal, are shown. *B*: Western blot analysis bands from wild-type and *Lep^ob^* antrums were quantified by densitometry and expressed relative to GAPDH. The summary graph demonstrates that the major proteins associated with ICC, enteric neurons, and smooth muscle were unchanged in the antrums of *Lep^ob^* compared with wild-type animals (unpaired Student *t* test). M, marker.](db181064f4){#F4}

Effects of the PTGS2 Inhibitor Valdecoxib on Electrical and Mechanical Activities of *Lep^ob^* Gastric Antrums {#s18}
--------------------------------------------------------------------------------------------------------------

Slow waves from *Lep^ob^* antrums are similar in waveform to wild-type slow waves after PGE~2~ application ([@B23],[@B24]). Thus, we recorded slow waves from *Lep^ob^* antrums before and in the presence of the PTGS2 inhibitor valdecoxib ([Fig. 5*A*--*C*](#F5){ref-type="fig"}). Under control conditions, *Lep^ob^* antrums exhibited slow waves with a frequency of 6.7 ± 0.8 min^−1^ and an amplitude of 23 ± 7.0 mV ([Fig. 5*B*, *D*, and *E*](#F5){ref-type="fig"}) (*n* = 6). (Note: recordings were made from region 5.) Valdecoxib (1 µmol/L) reduced slow wave frequency to 5.2 ± 1.1 min^−1^ ([Fig. 5*C* and *D*](#F5){ref-type="fig"}) (*P* = 0.0059), and slow wave amplitude increased to 27 ± 4.0 mV ([Fig. 5*C* and *E*](#F5){ref-type="fig"}) (*P* = 0.0161). Half-maximal duration of slow waves, ISWP, and RMP were not significantly affected by valdecoxib. Like slow waves, the amplitudes of phasic contractions increased, and contraction frequency decreased after valdecoxib application. Contractile force generated by *Lep^ob^* antrums averaged 1.04 ± 0.51 mN and occurred at 3.8 ± 1.5 min^−1^ ([Supplementary Fig. 5*A--D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)). In valdecoxib (1 µmol/L), contractile force increased to 2.15 ± 1.25 mN ([Supplementary Fig. 5*B* and *D*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*P* \< 0.001; *n* = 4) and frequency decreased to 2.5 ± 0.8 min^−1^ ([Supplementary Fig. 5*B* and *C*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*P* = 0.001; *n* = 5).

![PTGS2 inhibition normalizes disrupted antral pacemaker activity in *Lep^ob^* antrums. *A*: Continuous intracellular microelectrode recording from a *Lep^ob^* antrum under control conditions (no drugs) and after the addition of the PTGS2 inhibitor valdecoxib (1 μmol/L). Slow waves increased in amplitude and decreased in frequency. Intracellular recordings at a faster sweep speed before (*B*) and in the presence of valdecoxib (*C*). Traces show the changes in slow wave parameters. Summary of slow wave changes in slow wave frequency (*D*) and slow wave amplitude (*E*). Typical recordings of wild-type antrum under control conditions (*F*) and after the addition of valdecoxib (*G*). *H* and *I*: Summary of the effects of valdecoxib (Val) on slow wave frequency amplitude. Valdecoxib decreased frequency but had no effect on amplitude (paired Student *t* test). \**P* ≤ 0.05; \*\**P* ≤ 0.01.](db181064f5){#F5}

Valdecoxib also affected wild-type muscles. Slow waves were reduced in frequency from 3.3 ± 0.8 min^−1^ to 2.7 ± 0.8 min^−1^ ([Fig. 5*F*--*H*](#F5){ref-type="fig"}) (*P* = 0.003; *n* = 6). The ISWP increased from 11.9 ± 5.5 s to 18.5 ± 7.4 s (*P* = 0.016; *n* = 6). However, no differences were detected in amplitude ([Fig. 5*F*, *G*, and *I*](#F5){ref-type="fig"}), half-maximal duration or RMP. Valdecoxib (1 µmol/L) also influenced contractile activity in wild-type animals, reducing the frequency from 3.2 ± 0.5 min^−1^ to 2.7 ± 0.4 min^−1^ ([Supplementary Fig. 5*E*--*G*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*P* = 0.001; *n* = 7). A small increase in contractile amplitude in *Lep^ob^* antrums did not reach statistical significance ([Supplementary Fig. 5*E*, *F*, and *H*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)) (*n* = 6).

Video imaging revealed that PTGS2 inhibition also affected motility in *Lep^ob^* antrums. The spatiotemporal map in [Supplementary Fig. 5*I*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1) shows that *Lep^ob^* antrums exhibit frequent, weak contractions. After application of valdecoxib (1 µmol/L; 20 min), contractions became more robust and occurred at a frequency of 2.8 min^−1^ ([Supplementary Fig. 5*J*](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)).

Changes in mRNA Expression of Key Genes Associated With Prostaglandin Signaling in Gastric Antrums from *Lep^ob^* Mice {#s19}
----------------------------------------------------------------------------------------------------------------------

Chronic, subclinical inflammation is associated with type 2 diabetes, and chronic inflammation has been shown to underlie the development of insulin resistance in animal models of type 2 diabetes ([@B29]). As inflammation causes PTGS2 upregulation ([@B30]), qPCR was performed to determine whether PTGS2 and other enzymes involved in prostaglandin synthesis, its breakdown, and receptors involved in mediating its biological response were changed in *Lep^ob^* antrums. *Ptgs2* was significantly upregulated in *Lep^ob^* antrums ([Fig. 6](#F6){ref-type="fig"}) (*n* = 4; *P* = 0.0003). Likewise, expression of the terminal enzyme for PGE~2~ synthesis, *Ptges*, was also significantly increased ([Fig. 6](#F6){ref-type="fig"}) (*n* = 4; *P* = 0.0004). Expression of PGE~2~ receptor subtypes EP1, EP2, and EP3 (*Ptger1*, *Ptger2*, and *Ptger3*) was also increased in *Lep^ob^* antrums ([Fig. 6](#F6){ref-type="fig"}) (*n* = 4; *P* = 0.0007, 0.0005, and 0.0007, respectively), whereas expression of *Ptger4* (PGE~2~ receptor subtype EP4) was not altered. We also assessed the mRNA expression of *Ptgfr* and *Ptgir*, receptors for PGF~2α~ and PGI~2~, and both were significantly increased in *Lep^ob^* antrums ([Fig. 6](#F6){ref-type="fig"}) (*n* = 4; *P* = 0.0019 and 0.0002, respectively). Finally, *Hpgd* (15-hydroxyprostaglandin dehydrogenase), an enzyme involved in the breakdown of prostaglandins, was increased in diabetic antrums ([Fig. 6](#F6){ref-type="fig"}) (*n* = 4; *P* = 0.0018). Other enzymes involved in production and breakdown of prostaglandins, *Ptgs1* (prostaglandin-endoperoxide synthase 1) and *Ptgr1* (prostaglandin reductase 1), respectively, were not changed in *Lep^ob^* antrums. Because valdecoxib, a specific PTGS2 inhibitor, had significant effects on antral electrical and contractile behavior of *Lep^ob^* antrums ([Fig. 5](#F5){ref-type="fig"} and [Supplementary Fig. 5](http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db18-1064/-/DC1)), upregulation of gene transcripts likely plays a significant role in the changes in gastric motor activity in these diabetic animals.

![qPCR comparing the expression of several key genes involved in prostaglandin synthesis and signaling in antrums from wild-type and *Lep^ob^* mice. Bar graph depicts the fold change in prostaglandin-related gene transcripts. Several gene products were shown to be significantly upregulated in *Lep^ob^* antrums compared with wild-type controls: terminal *Ptges*, *Ptger1*, *Ptger2*, *Ptger3*, *Ptgs2*, PGF receptor (*Ptgfr*), *Ptgir*, and *Hpgd*. *Ptger4*, *Ptgr1*, and *Ptgs1* did not differ significantly in gene transcript expression between *Lep^ob^* antrums and wild-type controls (unpaired Student *t* test). \*\**P* ≤ 0.01; \*\*\**P* ≤ 0.001.](db181064f6){#F6}

Discussion {#s20}
==========

Patients with diabetes often suffer significant GI symptoms, including gastroparesis, which can significantly impair their quality of life ([@B31]). Previous studies suggested that an enteric neuropathy is the underlying cause of gastroparesis. A decrease in NOS1-containing inhibitory neurons, and changes in cholinergic excitatory neurons, have been reported in the GI tracts of diabetic animal models ([@B2],[@B32]). Reduced numbers of ICC have also been observed in diabetic GI muscles ([@B5],[@B6],[@B33]). More recently, increased numbers of ICC have been reported in *Lepr^db^* mice with rapid gastric emptying ([@B17]). Thus, reports on the underlying changes in enteric nerves and ICC vary considerably. Despite the number of studies that have reported changes in neuronal or ICC populations, little information has been garnered on functional changes that underlie gastroparesis associated with type 2 diabetes.

In this study, we used *Lep^ob^* mice, a type 2 diabetic animal model, to examine functional changes that occur in gastric electrical and mechanical activities. Electrical slow waves were increased in frequency and reduced in amplitude and associated contractions were more frequent and weaker in diabetic antrums compared with wild-type animals. Furthermore, electrical recordings made from nine defined antral recording sites revealed that slow waves were significantly reduced and, in some animals, could not be resolved at several sites in *Lep^ob^* antral muscles. These data would suggest that slow wave generation in some sites becomes ineffective and propagation of slow waves, necessary for coordinated gastric peristalsis and efficient chemomechanical breakdown of gastric contents, does not occur normally. Such loss of function could lead to delayed gastric emptying. This information was only detected following systematic electrical recordings from an array of multiple sites and would be undetected if single-recording sites or larger tissue preparations were used (i.e., isometric force measurements).

We found no evidence that the densities of NOS1^+^ neurons and ICC were altered in *Lep^ob^* mice. Recently, it has been reported that gene transcripts for NOS1 and VAChT, biomarkers for inhibitory and excitatory neurons, were slightly increased in gastric tissues from patients with idiopathic gastroparesis without diabetes ([@B34]). This study also revealed no significant changes in gene transcripts specific for ICC (e.g., *Kit* and *Ano1*) in these patients, although decreased *Pdgfra*, a marker for PDGFRα^+^ cells, was observed. In *Lep^ob^* mice, the density of PDGFRα^+^ cells, another specialized interstitial cell in GI muscles ([@B35]), appeared normal, as previously reported for gastric muscles of human patients with diabetes ([@B36]). Thus, considerable discrepancy exists in reports describing changes in enteric nerve and interstitial cell populations depending on the animal model or type of diabetes studied.

Rather than gross morphological or structural changes in neurons or interstitial cells, changes in slow wave activity in *Lep^ob^* mice appear to be due to abnormal prostaglandin production and responses. The conclusion that prostaglandins are involved stems from the observation that PTGS2 inhibition by valdecoxib resulted in slow wave frequency and amplitude returning toward normal values and contractile activity becoming more robust, similar to wild-type controls. Valdecoxib, at the concentration used in the current study, is reported to be a potent and selective inhibitor of PTGS2 versus PTGS1 in vitro and in vivo ([@B37]). Thus, the normalization of slow wave activity in *Lep^ob^* mice is likely be due to inhibition of PTGS2 rather than PTGS1. Application of PGE~2~ to wild-type antrums results in increased slow wave frequency and reduction in amplitude ([@B23],[@B24]), mimicking *Lep^ob^* antrum activity. The positive chronotropic effects of prostaglandins may occur via PTGER3, as specific agonists of this receptor increased pacemaker activity in isolated ICC and tissues ([@B25]). Stretch-dependent experiments on the gastric antrum revealed that length ramps produced membrane depolarization and chronotropic effects on pacemaker activity ([@B38]). These stretch-dependent responses were inhibited by indomethacin and absent in PTGS2-deficient mice. Stretch-dependent responses on *W/W^v^* mice that lack gastric ICC-IM were absent. These data suggested that antral ICC-IM are mechanosensitive, and chronotropic responses to length ramps were mediated via prostaglandin production by these cells ([@B38]).

Diabetes is associated with chronic, subclinical inflammation and considered an inflammatory disease ([@B29]). Macrophage-derived inflammation in adipose tissue can trigger insulin resistance ([@B39]). Changes in macrophage populations are reported to occur in diabetic and idiopathic gastroparesis. In the stomachs of these patients, there was loss of CD206^+^ anti-inflammatory macrophages and associated loss of ICC, suggesting that CD206^+^ macrophages are cryoprotective ([@B40],[@B41]). However, we did not observe a loss of antral ICC in the current study and cannot say whether an inflammatory response exists in *Lep^ob^* antrums. To explain the changes in gastric motor activity of *Lep^ob^* stomachs, we examined the expression of genes involved in the synthesis and breakdown PGE~2~, and its receptors, as these components of the prostaglandin pathway affect gastric motor activity ([@B20],[@B23],[@B24]). We found that *Ptgs2* gene transcripts were upregulated in *Lep^ob^* antrums. Furthermore, *Ptges*, which encodes microsomal PGE~2~ synthase, is also highly augmented in *Lep^ob^* antrums, providing an additional mechanism that could contribute to the apparent increase in PGE~2~ activity. PTGES is a terminal PGE synthase that converts PGH~2~ to PGE~2~ ([Fig. 7](#F7){ref-type="fig"}). Unlike other PGE synthases (PTGES2 and PTGES3), which are constitutively expressed, PTGES is induced by proinflammatory stimuli and has been observed to be upregulated in various inflammatory diseases, such as inflammatory bowel disease ([@B42]). In addition to PGE~2~ synthesis enzymes, we found that gene transcripts for multiple PGE~2~ receptors (*Ptger1*, *Ptger2*, and *Ptger3*) were also increased in diabetic antrums. This indicates that, along with increased PGE~2~ production, the tissue also has a greater capacity to respond to PGE~2~. Notably, *Ptger3*, encoding PTGER3, is one of the upregulated gene transcripts, and, as previously mentioned, it has been implicated as the receptor involved in the gastric motor effects of PGE~2~ ([@B24],[@B25]). Additionally, *Ptgfr* and *Ptgir*, which encode the receptors for PGF~2α~ and PGI~2~, respectively, were increased. Both PGF~2α~ and PGI~2~ are known to affect gastric motor activity, but PGF~2α~ does not affect gastric rhythmicity ([@B43]), and PGI~2~ had a much weaker effect on motility than PGE~2~ ([@B44]).

![Diagram depicting the prostanoid synthesis pathway and the effects of PGE~2~ on its receptor subtypes. Highlighted boxes identify prostaglandin-related genes that are upregulated in the gastric antrums of *Lep^ob^* tissues. We hypothesize that upregulation of PTGES, encoding microsomal PGE~2~ synthase, results in increased levels of PGE~2~, which in turn results in abnormal antral slow wave and contractile activity. The PTGER1--3 receptors are also upregulated and likely play a role in the altered gastric motor activity. IP~3~, inositol triphosphate.](db181064f7){#F7}

In this study, we did not observe changes in NOS1^+^ enteric neurons or ICC, contrasting with some previously published findings ([@B2],[@B6],[@B45]). An explanation for this disparity is the different approaches used to identify and quantify particular GI cell types. In previous studies, cross-section preparations of muscle tissues have simply been used to quantify cells of interest. This technique has received criticism and is currently generally not a well-accepted approach to determine changes in GI muscles ([@B46]). Our immunohistochemical analysis was performed using confocal microscopy on six randomly selected areas of whole mounts imaging the entire muscle thickness. Thus, the approach taken in this study should accurately reflect the genuine situation of cellular networks of *Lep^ob^* antrums. Another possible reason is that we used an animal model of type 2 diabetes, whereas the majority of previously studies have investigated type 1 or streptozotocin-induced diabetes.

Although we have observed profound changes in the prostaglandin pathway in *Lep^ob^* antrums, we also found that PTGS2 inhibition affected slow wave activity in wild-type mice. It has previously been shown that PTGS2 is constitutively expressed in antral tissues of wild-type mice ([@B20]). Because PTGS2 inhibition altered pacemaker activity and contractile responses in *Lep^ob^* and wild-type antrums, this suggests ongoing PGE~2~ production in wild-type tissues, although production is upregulated in *Lep^ob^* antrums.

In conclusion, pacemaker activity in the gastric antrum is disrupted in a type 2 diabetic mouse model. Slow waves were increased in frequency and reduced in amplitude, resulting in phasic contractions that were augmented in frequency and greatly reduced in amplitude. These changes may be involved in the pathogenesis of diabetic gastroparesis. The disruption in pacemaker activity is likely the result of increased prostaglandin synthesis enzymes and receptors for PGE~2~. These findings raise the exciting possibility of a novel treatment for diabetic gastroparesis by inhibition of prostaglandin synthesis.
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